http://rdf.ncbi.nlm.nih.gov/pubchem/patent/IL-153109-A0
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d202e9e866984fe229f6facc38f1d740 |
| classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-40 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K- http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-66 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F- |
| filingDate | 1998-07-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2003-06-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | IL-153109-A0 |
| titleOfInvention | A pharmaceutical composition useful for inhibiting bone resorption in a human comprising alendronic acid or pharmaceutically acceptable salt thereof or a mixture thereof |
| priorityDate | 1997-07-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
| Predicate | Subject |
|---|---|
| isDiscussedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419554994 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2088 |
Total number of triples: 13.